Topic: MS

Anti-CD20 therapies – Mechanisms of action

May 25, 2021  

MS Clinics Network updates COVID vaccine guidance

May 3, 2021  

Are trial data generalizable to MS population?

April 27, 2021  

Few vaccine responders with fingolimod, ocrelizumab

April 23, 2021  

Early, effective MS treatment revisited

April 8, 2021  

ACTRIMS FORUM 2021 – Highlights

March 2, 2021  

ACTRIMS FORUM 2021 – Highlights

March 1, 2021  

COVID-19 vaccines and Multiple sclerosis – update

February 26, 2021  

COVID-19 vaccines and Multiple sclerosis

February 11, 2021  

Novel anti-CD20 monoclonal approved in Canada for MS

January 27, 2021